Pacific Eye Associates
4.8
102 reviews
Dr. Emily Sarah Charlson
4.8
102 reviews
  • 5
  • 4
  • 3
  • 2
  • 1
  • Sort By:
    Google My Business
    Kimiko Klein Via Google My Business
    Dr. Charlson did a bilateral eyelid lift to improve my peripheral vision and prevent my eyelids from pressing down on my eyelashes. She explained the procedure clearly, answered all my questions, and , most importantly, the results are pretty spectacular. There was also no real discomfort after surgery. I am quite pleased with my new look.
    Google My Business
    Pamela Dickey Via Google My Business
    Dr. Charlson is friendly and listens to patient symptoms and concerns. She is a great diagnostician, and I have the utmost confidence In her medical judgement.
    Google My Business
    Shannon Cotter Via Google My Business
    Dr. Charlson was great! Very knowledgeable and took the time to listen to what was going on.
    Google My Business
    Kathy Donaldson Via Google My Business
    Dr. Charlson was fantastic. She was very thorough in her exam and answered all my questions. Very kind and compassionate.
    Google My Business
    joseph blum Via Google My Business
    << < 17 18 19 20 21 > >>
    Dr. Emily Sarah Charlson
    Dr. Emily Sarah Charlson
    +1(415) 923-3007
    ABOUT
    Dr. Emily Sarah Charlson
    Ophthalmologist Emily Charlson, M.D., Ph.D. is a specialist in oculofacial, orbital, and aesthetic plastic surgery. She is an expert in eyelid, orbit, and tear drainage surgery including droopy eyelids and eyebrows, eyelid bags, eyelid cancer/Mohs reconstruction, eyelid malpositions, thyroid eye disease/decompression, orbital tumors or masses, and tearing due to tear drainage system problems. Dr. Charlson implements the latest medical and surgical therapies including biologics for orbital carcinoma, corneal neurotization (nerve grafting) to restore corneal sensation, and Teprotumumab for thyroid eye disease treatment. Cosmetically, she performs aesthetic eyelid, eyebrow, and midface surgery, as well as injectable fillers/botox and skin resurfacing for full facial rejuvenation. Using the latest minimally invasive techniques, she strives to balance eye function and aesthetics with patient-centered customized approaches. Dr. Charlson graduated from The University of Pennsylvania after a 7-year dual degree MD-PhD medical scientist training program. Her Ph.D. work centered on genomics, deep-sequencing, and bioinformatics with the Human Microbiome Project. She presented her work at numerous national and international conferences with publications in Nature Biotechnology, Nature Methods, and others. Her work is recognized with the University of Pennsylvania Institute for Translational Medicine & Therapeutics Prize for Clinical Translational Research and Jeffery W. Berger Ophthalmology Research Award, among others. She completed her ophthalmology residency at the University of California, Irvine. Here, Dr. Charlson led the development of a novel digital prosthetic eye using OLED micro-screens and 3D printed glasses incorporating a convolutional neural network artificial intelligence algorithm for pupil tracking funded by an Institute for Clinical Translational Research Rising Investigator NIH Grant. This work was presented at several international conferences and recognized with a UCI Research Excellence Award and American Society of Ophthalmic Plastic Surgery (ASOPRS) Innovation & Achievement Award. Dr. Charlson pursued an intensive 2-year American Society of Ophthalmic Plastic Surgery fellowship in oculofacial, orbit, and aesthetics as of one of only a handful of fellows annually selected by ASOPRS with Byers Eye Institute at Stanford University. She received a Heed Fellowship Award from the Society of Heed Fellows and lead significant contributions to survival analysis of globe/eye salvaging therapy for orbital malignancy, use of immune-checkpoint inhibitors for advanced orbital carcinoma, and new methods of corneal neurotization. Most recently, she designed novel artificial intelligence algorithms to predict thyroid eye disease development in newly diagnosed Graves’ and Hashimoto’s disease patients useful for evaluating the risk of thyroidectomy vs radioactive iodine ablation (RAI) in thyroid patients. This work was recognized at international conferences and awarded the ASOPRS Innovation & Achievement Award. Outside of medicine, she loves running/swimming/cycling as a triathlete, taking her two Rhodesian Ridgeback puppies to the beach, and traveling internationally with her family.